孤儿药认定-话题@MedSci

#孤儿药认定#

17篇内容 | 1079人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1634488, encodeId=22f7163448892, content=<a href='/topic/show?id=03454543528' target=_blank style='color:#2F92EE;'>#孤儿药认定#</a>, objectTitle=全球首创！康方生物PD-1/CTLA-4双抗治疗宫颈癌获美国FDA孤儿药认定, objectType=article, longId=207633, objectId=bf5620e63327, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bf5620e63327, replyNumber=0, likeNumber=65, createdTime=2021-10-12, rootId=0, userName=dzx0922896, userId=f66f22187170, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bf5620e63327, moduleTitle=全球首创！康方生物PD-1/CTLA-4双抗治疗宫颈癌获美国FDA孤儿药认定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bf5620e63327)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1634487, encodeId=f503163448e1d, content=<a href='/topic/show?id=03454543528' target=_blank style='color:#2F92EE;'>#孤儿药认定#</a>, objectTitle=细胞接合剂AFM13治疗T细胞淋巴瘤：已获FDA孤儿药认定, objectType=article, longId=191251, objectId=1c771912519e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1c771912519e, replyNumber=0, likeNumber=60, createdTime=2020-04-02, rootId=0, userName=dzx0922896, userId=f66f22187170, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1c771912519e, moduleTitle=细胞接合剂AFM13治疗T细胞淋巴瘤：已获FDA孤儿药认定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1c771912519e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1634484, encodeId=cebf1634484e8, content=<a href='/topic/show?id=03454543528' target=_blank style='color:#2F92EE;'>#孤儿药认定#</a>, objectTitle=α-1抗胰蛋白酶（A1AT）缺乏症治疗或取得重大突破：DCR-A1AT获得孤儿药认定, objectType=article, longId=190435, objectId=1500190435a1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1500190435a1, replyNumber=0, likeNumber=59, createdTime=2020-07-10, rootId=0, userName=dzx0922896, userId=f66f22187170, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1500190435a1, moduleTitle=α-1抗胰蛋白酶（A1AT）缺乏症治疗或取得重大突破：DCR-A1AT获得孤儿药认定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1500190435a1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1634486, encodeId=51d4163448654, content=<a href='/topic/show?id=03454543528' target=_blank style='color:#2F92EE;'>#孤儿药认定#</a>, objectTitle=基因疗法抗击卵巢癌：欧洲药品管理局授予GEN-1孤儿药认定, objectType=article, longId=190731, objectId=6e06190e31bf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6e06190e31bf, replyNumber=0, likeNumber=131, createdTime=2020-05-16, rootId=0, userName=dzx0922896, userId=f66f22187170, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6e06190e31bf, moduleTitle=基因疗法抗击卵巢癌：欧洲药品管理局授予GEN-1孤儿药认定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6e06190e31bf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1634481, encodeId=3d2416344817d, content=<a href='/topic/show?id=03454543528' target=_blank style='color:#2F92EE;'>#孤儿药认定#</a>, objectTitle=多靶标蛋白药物：美国FDA授予MP0250治疗多发性骨髓瘤的孤儿药认定, objectType=article, longId=185458, objectId=677c185458b1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=677c185458b1, replyNumber=0, likeNumber=55, createdTime=2020-04-20, rootId=0, userName=dzx0922896, userId=f66f22187170, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=677c185458b1, moduleTitle=多靶标蛋白药物：美国FDA授予MP0250治疗多发性骨髓瘤的孤儿药认定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=677c185458b1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1634477, encodeId=e71b16344e787, content=<a href='/topic/show?id=03454543528' target=_blank style='color:#2F92EE;'>#孤儿药认定#</a>, objectTitle=Leriglitazone治疗Friedreich共济失调：已获欧洲委员会的孤儿药认定, objectType=article, longId=182982, objectId=f801182982f8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f801182982f8, replyNumber=0, likeNumber=56, createdTime=2020-01-23, rootId=0, userName=dzx0922896, userId=f66f22187170, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f801182982f8, moduleTitle=Leriglitazone治疗Friedreich共济失调：已获欧洲委员会的孤儿药认定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f801182982f8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1634480, encodeId=f518163448094, content=<a href='/topic/show?id=03454543528' target=_blank style='color:#2F92EE;'>#孤儿药认定#</a>, objectTitle=日本厚生劳动省：授予tepotinib治疗MET基因改变的NSCLC患者的孤儿药认定, objectType=article, longId=183347, objectId=97cd18334e4f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=97cd18334e4f, replyNumber=0, likeNumber=58, createdTime=2020-01-26, rootId=0, userName=dzx0922896, userId=f66f22187170, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=97cd18334e4f, moduleTitle=日本厚生劳动省：授予tepotinib治疗MET基因改变的NSCLC患者的孤儿药认定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=97cd18334e4f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1634483, encodeId=465f1634483bf, content=<a href='/topic/show?id=03454543528' target=_blank style='color:#2F92EE;'>#孤儿药认定#</a>, objectTitle=FDA授予Umbralisib孤儿药认定，以治疗滤泡性淋巴瘤（FL）, objectType=article, longId=189499, objectId=623b18949984, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=623b18949984, replyNumber=0, likeNumber=58, createdTime=2021-02-12, rootId=0, userName=dzx0922896, userId=f66f22187170, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=623b18949984, moduleTitle=FDA授予Umbralisib孤儿药认定，以治疗滤泡性淋巴瘤（FL）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=623b18949984)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1634482, encodeId=2cb01634482d4, content=<a href='/topic/show?id=03454543528' target=_blank style='color:#2F92EE;'>#孤儿药认定#</a>, objectTitle=FDA授予PR001治疗神经衰弱性戈谢病（nGD）的孤儿药认定, objectType=article, longId=188097, objectId=89f018809e88, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=89f018809e88, replyNumber=0, likeNumber=56, createdTime=2020-06-20, rootId=0, userName=dzx0922896, userId=f66f22187170, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=89f018809e88, moduleTitle=FDA授予PR001治疗神经衰弱性戈谢病（nGD）的孤儿药认定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=89f018809e88)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1634485, encodeId=88051634485ef, content=<a href='/topic/show?id=03454543528' target=_blank style='color:#2F92EE;'>#孤儿药认定#</a>, objectTitle=瑞德西韦获得FDA孤儿药认定, objectType=article, longId=190722, objectId=0e7b190e22f7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0e7b190e22f7, replyNumber=0, likeNumber=52, createdTime=2020-07-14, rootId=0, userName=dzx0922896, userId=f66f22187170, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0e7b190e22f7, moduleTitle=瑞德西韦获得FDA孤儿药认定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0e7b190e22f7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1634478, encodeId=97d916344e836, content=<a href='/topic/show?id=03454543528' target=_blank style='color:#2F92EE;'>#孤儿药认定#</a>, objectTitle=LM-030治疗Netherton综合征：已获欧洲委员会的孤儿药认定, objectType=article, longId=182983, objectId=826118298353, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=826118298353, replyNumber=0, likeNumber=58, createdTime=2020-02-07, rootId=0, userName=dzx0922896, userId=f66f22187170, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=826118298353, moduleTitle=LM-030治疗Netherton综合征：已获欧洲委员会的孤儿药认定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=826118298353)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1634479, encodeId=ccd016344e94d, content=<a href='/topic/show?id=03454543528' target=_blank style='color:#2F92EE;'>#孤儿药认定#</a>, objectTitle=日本厚生劳动省：授予Polatuzumab vedotin治疗弥漫性大B细胞淋巴瘤的孤儿药认定, objectType=article, longId=183346, objectId=525e183346c6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=525e183346c6, replyNumber=0, likeNumber=119, createdTime=2020-08-31, rootId=0, userName=dzx0922896, userId=f66f22187170, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=525e183346c6, moduleTitle=日本厚生劳动省：授予Polatuzumab vedotin治疗弥漫性大B细胞淋巴瘤的孤儿药认定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=525e183346c6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1634474, encodeId=9f5616344e490, content=<a href='/topic/show?id=03454543528' target=_blank style='color:#2F92EE;'>#孤儿药认定#</a>, objectTitle=Principia 制药宣布PRN1008获得FDA孤儿药认定用于治疗免疫性血小板减少性紫癜, objectType=article, longId=151535, objectId=817b1515353f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=817b1515353f, replyNumber=0, likeNumber=56, createdTime=2019-04-19, rootId=0, userName=dzx0922896, userId=f66f22187170, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=817b1515353f, moduleTitle=Principia 制药宣布PRN1008获得FDA孤儿药认定用于治疗免疫性血小板减少性紫癜, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=817b1515353f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1634476, encodeId=51a116344e69d, content=<a href='/topic/show?id=03454543528' target=_blank style='color:#2F92EE;'>#孤儿药认定#</a>, objectTitle=亨特氏综合症的治疗：DNL310取得孤儿药认定, objectType=article, longId=168249, objectId=c75216824903, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c75216824903, replyNumber=0, likeNumber=70, createdTime=2020-01-15, rootId=0, userName=dzx0922896, userId=f66f22187170, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c75216824903, moduleTitle=亨特氏综合症的治疗：DNL310取得孤儿药认定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c75216824903)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1634473, encodeId=3d3216344e3ea, content=<a href='/topic/show?id=03454543528' target=_blank style='color:#2F92EE;'>#孤儿药认定#</a>, objectTitle=KL1333获FDA孤儿药认定, objectType=article, longId=136292, objectId=d17f13629232, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d17f13629232, replyNumber=0, likeNumber=63, createdTime=2019-03-23, rootId=0, userName=dzx0922896, userId=f66f22187170, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d17f13629232, moduleTitle=KL1333获FDA孤儿药认定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d17f13629232)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1634475, encodeId=95f116344e526, content=<a href='/topic/show?id=03454543528' target=_blank style='color:#2F92EE;'>#孤儿药认定#</a>, objectTitle=Zepsyre（lurbinectedin）在小细胞肺癌治疗中获欧洲药品管理局孤儿药认定, objectType=article, longId=158995, objectId=d85315899529, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d85315899529, replyNumber=0, likeNumber=43, createdTime=2019-03-27, rootId=0, userName=dzx0922896, userId=f66f22187170, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d85315899529, moduleTitle=Zepsyre（lurbinectedin）在小细胞肺癌治疗中获欧洲药品管理局孤儿药认定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d85315899529)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1634472, encodeId=1f3916344e28d, content=<a href='/topic/show?id=03454543528' target=_blank style='color:#2F92EE;'>#孤儿药认定#</a>, objectTitle=Syros全球首创白血病药SY-1425获孤儿药认定, objectType=article, longId=110611, objectId=136e11061146, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=136e11061146, replyNumber=0, likeNumber=83, createdTime=2018-05-06, rootId=0, userName=dzx0922896, userId=f66f22187170, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=136e11061146, moduleTitle=Syros全球首创白血病药SY-1425获孤儿药认定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=136e11061146)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

孤儿药认定

2020-05-29

dzx0922896 (审核中...)

前往app查看评论内容

#孤儿药认定#

全球首创！康方生物PD-1/CTLA-4双抗治疗宫颈癌获美国FDA孤儿药认定

2021-10-12

dzx0922896 (审核中...)

前往app查看评论内容

#孤儿药认定#

细胞接合剂AFM13治疗T细胞淋巴瘤：已获FDA孤儿药认定

2020-04-02

dzx0922896 (审核中...)

前往app查看评论内容

#孤儿药认定#

α-1抗胰蛋白酶（A1AT）缺乏症治疗或取得重大突破：DCR-A1AT获得孤儿药认定

2020-07-10

dzx0922896 (审核中...)

前往app查看评论内容

#孤儿药认定#

基因疗法抗击卵巢癌：欧洲药品管理局授予GEN-1孤儿药认定

2020-05-16

dzx0922896 (审核中...)

前往app查看评论内容

#孤儿药认定#

多靶标蛋白药物：美国FDA授予MP0250治疗多发性骨髓瘤的孤儿药认定

2020-04-20

dzx0922896 (审核中...)

前往app查看评论内容

#孤儿药认定#

Leriglitazone治疗Friedreich共济失调：已获欧洲委员会的孤儿药认定

2020-01-23

dzx0922896 (审核中...)

前往app查看评论内容

#孤儿药认定#

日本厚生劳动省：授予tepotinib治疗MET基因改变的NSCLC患者的孤儿药认定

2020-01-26

dzx0922896 (审核中...)

前往app查看评论内容

#孤儿药认定#

FDA授予Umbralisib孤儿药认定，以治疗滤泡性淋巴瘤（FL）

2021-02-12

dzx0922896 (审核中...)

前往app查看评论内容

#孤儿药认定#

FDA授予PR001治疗神经衰弱性戈谢病（nGD）的孤儿药认定

2020-06-20

dzx0922896 (审核中...)

前往app查看评论内容

#孤儿药认定#

瑞德西韦获得FDA孤儿药认定

2020-07-14

dzx0922896 (审核中...)

前往app查看评论内容

#孤儿药认定#

LM-030治疗Netherton综合征：已获欧洲委员会的孤儿药认定

2020-02-07

dzx0922896 (审核中...)

前往app查看评论内容

#孤儿药认定#

日本厚生劳动省：授予Polatuzumab vedotin治疗弥漫性大B细胞淋巴瘤的孤儿药认定

2020-08-31

dzx0922896 (审核中...)

前往app查看评论内容

#孤儿药认定#

Principia 制药宣布PRN1008获得FDA孤儿药认定用于治疗免疫性血小板减少性紫癜

2019-04-19

dzx0922896 (审核中...)

前往app查看评论内容

#孤儿药认定#

亨特氏综合症的治疗：DNL310取得孤儿药认定

2020-01-15

dzx0922896 (审核中...)

前往app查看评论内容

#孤儿药认定#

KL1333获FDA孤儿药认定

2019-03-23

dzx0922896 (审核中...)

前往app查看评论内容

#孤儿药认定#

Zepsyre（lurbinectedin）在小细胞肺癌治疗中获欧洲药品管理局孤儿药认定

2019-03-27

dzx0922896 (审核中...)

前往app查看评论内容

#孤儿药认定#

Syros全球首创白血病药SY-1425获孤儿药认定

2018-05-06

科室
- - 订阅+
  - 更多科室
工具
服务